Register to chat with like-minded investors on our interactive forums.
The current BNR market cap is 57.45M. The company's latest EPS is CNY and P/E is N/A.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 146.27M | 127.57M | 121.09M | 125.62M | 135.53M |
| Operating Income | -135.72M | -178.82M | -166.32M | -125.83M | -111.22M |
| Net Income | -131.24M | -174.98M | -162.21M | -121.55M | -108.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 381.68M | 429.9M | 507.86M | 563.24M | 537.44M |
| Operating Income | -169.09M | -412.41M | -797.06M | -980.41M | -669.32M |
| Net Income | -334.17M | -471.92M | -796.7M | -971.23M | -653.69M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.33B | 1.17B | 1.04B | 984.93M | 1.02B |
| Total Liabilities | 363.15M | 303.75M | 271.59M | 268.09M | 345.54M |
| Total Equity | 967.61M | 862.97M | 768.41M | 716.83M | 677.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 847.56M | 2.66B | 2.28B | 1.59B | 1.04B |
| Total Liabilities | 212.02M | 242.02M | 433.28M | 429.13M | 271.59M |
| Total Equity | -891.49M | 2.42B | 1.85B | 1.16B | 768.41M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -192.35M | -239.76M | -255.78M | -40.21M | -81.05M |
| Investing | -6.99M | -8.97M | -9.3M | -2.39M | -2.61M |
| Financing | -1.04M | -46.92M | -48.83M | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | -228.04M | -73.54M | -477.89M | -456.81M | -255.78M |
| Investing | -346.66M | -109.31M | 81.7M | -7.46M | -9.3M |
| Financing | 571.74M | 2.17B | -52.9M | -86.24M | -48.83M |
| Market Cap | 57.45M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 10.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.42 (7.39%) |
| Company Name | Burning Rock Biotech Ltd |
| Address |
po box 309 grand cayman KY1 1104 |
| Website | https://www.brbiotech.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
